The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000502:physiology; D002395:Catecholamines / Q000378:metabolism; D004149:Dioxoles / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005116:Extrapyramidal Tracts / Q000502:physiology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D008032:Limbic System / Q000502:physiology; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000502:physiology; D013747:Tetrabenazine / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D002395:Catecholamines; D004149:Dioxoles; D007211:Indoles; D010879:Piperazines; D011743:Pyrimidines; D011807:Quinolizines; D014665:Vasodilator Agents; D014191:Tranylcypromine; D014443:Tyrosine; D009526:Nialamide; D013747:Tetrabenazine